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skin. Williams et al. (1960) quote several studies in which it was shown that the wound sepsis rate was higher in patients who were nasal carriers.
Adequate skin-cleansing with antibacterial agents may sterilize the skin surface, but organisms exuded from sweat and sebaceous glands may in tirne contaminate porous skin towels and the wound. Only careful exclusion of the patient's skin surface will prevent this route of entry. Lowbury and Lilly (1960) have shown that preparation of the skin with antiseptics may reduce the number of bacteria but not eliminate them completely. It is therefore important to attempt to protect the wound from the entry of organisms from the surrounding skin even though it may have been thoroughly prepared.
While we do not deny that wounds may be infected from many sources within and without the theatre, demonstration of the route and source of specific infections is most difficult. All possible sources of organisms should therefore be eradicated or excluded. This paper focuses attention chiefly on one source, one that is often neglected-the patient himself at operation.
Summary and Conclusions New techniques of skin preparation and skin towelling were introduced into the Surgical Professorial Unit at St. Thomas's Hospital in January, 1959 . In the ensuing three years a fall in wound sepsis rate was observed compared with the previous four years.
It is stuggested that one of the important sources of organisms infecting surgical wounds may be the patient's own skin. Good exclusion of the skin surface from the wound can be obtained with modem methods.
Silicone fluids have been incorporated into ointments and barrier creams since their properties became generally known. Their main uses have been as vehicles for medicaments (Laumanns, 1958) and to protect the skin against discharges such as around colostomy wounds, napkin areas in infants, and folds of skin macerated by intertrigo (Wigley, Calnan, Meara, and Seville, 1952) . Smith, Day, and Zimmerman (1953) found a silicone cream more effective than other barrier creams against eczematogenous contact allergens. M. A. Cooke (personal communication, 1961 ) also found a delayed and reduced area of reaction in a procaine-sensitive patient by applying a silicone and methyl cellulose emulsion to the skin for four days prior to the application of 2% procaine, compared with control sites similarly treated with a standard barrier cream or left unprotected.
Silicone fluids were chosen because they are inert: they protect the skin and permit normal healing to take place (Morrow, 1954) . They were found particularly valuable against aqueous systems whether from body discharges or in protecting the skin from outside contact, as in hydrotherapy (Accart, 1957) .
Other workers (Bateman, 1956; James, 1956 Roberts, 1959 ) have used silicone creams in the prevention of decubitus ulcer, claiming not only that they were effective but that they also saved the nurses' time. Roberts and Williams (1957) first described silicone barrier creams in domiciliary nursing and found them so successful that they instituted them throughout the nursing services for which they were responsible.
Since nearly all the work on decubitus ulcers had been with silicone barrier creams, although Brusca (1956) and Roberts (1962a) Nurses were not directed into following a particular method; they were permitted to elect their own provided they followed it through the three-months trial. In this way it was hoped that bias due to enthusiasm would be eliminated. All cases where a skin disorder was already present were included in the trial, as were cases where the onset of such conditions seemed likely.
The superintendents held meetings with their nurses to make sure what was expected of them. The nurses were asked to record on a simple form the progress of each case. All patients who were receiving skin toilet were included: they were of both sexes, of a wide age range, and suffered from a variety of disorders. They were classified according to the condition of their skin at the start of the trial, and these fell into two broad groups of those with normal and those with abnormal skin. The numbers in each group were 101 and 91 respectively. We decided to exclude skin conditions which deteriorated within 48 hours of death, and these we called terminal cases, as we considered that deterioration was inevitable and the small number of deaths expected might by mischance all fall in one group.
It transpired that their removal from the analyses did not affect the result.
Since patients were admitted to the trial over the whole of the three months and were included in the trial in every case where the treatment period exceeded 13 days, whether a patient was " cured " or " improved " may have depended on the length of time he had been under treatment. For that reason and also because of the small number of patients in the trial it was thought best to combine the two categories of "cured and improved" and compare them with the combined " no change and deteriorated" groups.
The results of this trial (Tables I and II) indicated that there might be an advantage in using a higher It was therefore decided to extend the trial, using 100% silicone sprays in freon-operated canisters. As solubility in ethanol was no longer a factor of importance, any of the silicone fluids could now be used, and the official B.P.C. preparation dimethicone (MS 200/350 centistokes fluid) was compared with the MS 555 fluid. The two trials ran for three months each, but in the second trial an initial shortage of the dimethicone-filled canisters meant that many more cases were treated with the MS 555 fluid.
The forms were completed by the nurses conscientiously and with an accuracy which indicated great interest on their part. Very few in the first trial had to be referred back to them for elucidation and none in the second. The forms were collected and transferred to punch cards (Copeland Chatterton) for analysis. The information on the basic record was checked by us jointly against the card before the analysis was made.
Results of First Trial
In the first trial a comparison was made of (1) Table II shows the results of the four different methods compared in patients with various skin conditions. Three categories of abnormal skin were defiled: these were decubitus ulcer of any size, the pre-ulcer state (which was a familiar sign to the nurses), and a rash, whether specified as a urine rash or unspecified. There were 35 patients with ulcers (one of them terminal), 32 patients in a pre-ulcer state (with a second terminal case), and 24 patients with a rash. Silicones were not sprayed on the ulcers but were used to protect the surrounding intact but unhealthy skin. In all other conditions the silicones were sprayed directly on to the lesions. The numbers are small, but such evidence as there is indicates that pure MS 555 fluid appears to have an excellent protective effect on normal skin.
Patients with an Abnormal Skin at Entry into Trial. There were 60 patients in this series, of whom 42 were treated with MS 555 and 18 with MS 200. We grouped all skin conditions (decubitus ulcer, per-ulcer state, and rashes) and both sexes together and compared the effectiveness of the two silicones. Only 55% of the MS 200 series were cured or improved compared with 81 % of the MS 555 series. The standard of error of the difference between these percentages is 13, and 55 c +2 S.E.=81, so that the difference is of borderline significance at the 5% level. In established decubitus ulcer there is no evidence that MS 555 is more effective than MS 200. With the former, 14 were "cured and improved " and 6 showed " no change and deteriorated " against 8 and 3 respectively for MS 200. This is to be expected, for the ulcers themselves were treated by other means. The beneficial effect is on diseased skin which has not yet ulcerated: 20 C + I and 2 NC + D for MS 555 against 2 C+ I and 5 NC+D for MS 200. The standard error of the difference between these two percentages is 18, so that the difference is over three times the S.E.
Discussion
The evidence from either of the two trials is not in itself very strong, but the two together, although they cannot be directly added (because only the MS 555 was used in the first trial), make us more confident that MS 555 has a positive healing action.
In order to look for bias we examined the characteristics of the two groups treated by the various methods. Mention has already been made of the skew distribution of those with healthy skins who were treated by the orthodox method in the first trial. In the second trial the groups were analysed for age, sex, disease code, and incontinence (urinary, faecal, or both). For some unexplained reason proportionately more women were treated with MS 200 than MS 555, but there was no difference in age, incontinence, or the types of disease from which these patients suffered.
There was no difference in the percentage success of the 5% MS 555 silicone spray compared with the 100%, but the pure spray is far more acceptable to the The mode of action of methyldopa (alpha-methyl-3,4-dihydroxy-l-phenylalanine) in lowering blood-pressure is not fully understood. Several investigators (Sourkes, 1954; Smith, 1959; Oates et al., 1960) have shown that the drug inhibits the decarboxylation of dopa and other amino-acids and thus diminishes the production of noradrenaline and serotonin in the brain and other tissues. It has since been suggested by Gillespie et al. (1962) that because methyldopa has a sedative as well as a hypotensive action, properties not shared by other decarboxylating agents. the site of action may well be central. These same authors have shown that 15% to 30%' of an oral dose is absorbed in the gastro-intestinal tract and that the drug is excreted largely unaltered in the urine. The blood levels reach a maximum in two to four hours after administration and fall rapidly over the succeeding four to six hours.
Material and Methods
Up to the present time five female and 15 male hvpertensive patients, whose ages varied from 36 to 61 vears, were treated with methyldopa for periods of four weeks to six months. Of the 20 patients, 16 were regarded as having primary or essential hypertension, but it must be emphasized that renal arteriography was not performed in any of them and thus a renal cause was not definitely excluded. All the patients had thickened peripheral arterial walls, fundal changes, and electrocardiographic evidence of left ventricular hypertrophy; almost all of them had clinical and radiographic evidence of left ventricular hypertrophy; and some had albuminuria (Table I ). All warranted treatment with a hypotensive drug. In addition to the clinical features the initial blood-urea level is shown in Table I because it is an estimation of such prognostic importance.
